The article reports on the result of a meta-analysis on the role of liraglutide, an injectable drug treatment for type2 diabetes, to the reduction of cholesterol and other risk factors for heart disease. It notes the association of liraglutide with greater reductions in the proportion of ...
The efficacious strategies for curing type 2 diabetes mainly relied on the drugs including oral hypoglycemic drugs [9], and injectable preparation [10], e.g. insulin [11] or GLP-1 receptor agonist [12] and so on. The general commoditized oral hypoglycemic drugs are metformin drugs (...
Diabetes nutrition made easy — in just 10 mins a weekGet our free 10-minute nutrition micro-lessons to learn how changing the way you eat can have a big impact on your health and how you feel.SIGN UP NOWMedication guidelinesDifferent types of medication can reduce blood sugar in people wi...
Semaglutide, marketed as Ozempic, Rybelsus, and Wegovy, is a GLP-1 receptor agonist that helps to regulate blood sugar levels and promote weight loss. This medication is especially effective in managing type 2 diabetes and is available in both injectable and oral forms. Semaglutide enhances the...
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) were first introduced for the treatment of type 2 diabetes (T2D) in 2005. Despite the
A new trial has discovered that individuals suffering from “blinding” headaches, known as Idiopathic Intracranial Hypertension (IIH), could potentially be treated with an injectable peptide typically used for type 2 diabetes. The study, published in the journalBrain, presents the results of a phas...
having been a diabetes sufferer for more than 20 years. He found he regularly couldn't remember if he had injected his insulin and realised that he was not the only person to whom this was happening. So he decided to find a solution for this and other problems related to his disease, ...
Understanding Semaglutide: Semaglutide, originally developed as a treatment for type 2 diabetes, has garnered attention for its potential as a weight loss aid. This injectable medication belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking the action of a hormone...
Semaglutide has emerged as a significant advancement in the field of weight management. Initially developed as a treatment for type 2 diabetes, the drug gained widespread attention afterclinical trialsshowed it reduced baseline body weight by approximately 10%-15%. Weekly injectable medications like sem...
On September 30, 2022, Beijing Peptide Biomedical Technology Co., Ltd. (Bejing Peptide) Semaglutide (ZT001) injection was officially accepted by CDE. Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight manag...